Wave Life Sciences (WVE)
Develops PRISM-based RNA medicines across editing, silencing, splicing, and RNAi.
$4.37
vs last close+0.12 (+2.70%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.33
Revenue estimate
$5.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Jul '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$0.17−$0.29−$0.31−$0.32−$0.30−$0.13−$0.34Pending
Estimate−$0.17−$0.27−$0.29−$0.30−$0.28−$0.34−$0.30−$0.33
Surprise+200.0%−7.4%−6.9%−6.7%−7.1%+61.8%−13.4%—
RevenueReportedEstimate
Mar '25May '25Jul '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$83.7M$9.2M$8.7M$7.6M$17.2M$38.2M$2.3MPending
Estimate$12.2M$14.4M$9.9M$16.3M$16.1M$8.5M$7.4M$5.0M
Surprise+588.3%−36.4%−11.7%−53.5%+7.4%+352.6%−69.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.40 | — | — |
| Sep 2027 | −$0.38 | — | — |
| Jun 2027 | −$0.39 | — | — |
| Mar 2027 | −$0.36 | — | — |
| Dec 2026 | −$0.34 | — | — |
| Nov 2026 | −$0.33 | — | — |
| Jul 2026 | −$0.30 | −$0.34 | −13.4% |
| Apr 2026 | −$0.34 | −$0.13 | +61.8% |
| Feb 2026 | −$0.28 | −$0.30 | −7.1% |
| Nov 2025 | −$0.30 | −$0.32 | −6.7% |
| Jul 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.40 | — | — | $8.2M | — | — | — |
| Sep 2027 | −$0.38 | — | — | $5.5M | — | — | — |
| Jun 2027 | −$0.39 | — | — | $4.7M | — | — | — |
| Mar 2027 | −$0.36 | — | — | $4.3M | — | — | — |
| Dec 2026 | −$0.34 | — | — | $6.1M | — | — | — |
| Nov 9, 2026 | −$0.33 | — | — | $5.0M | — | — | — |
| Jul 30, 2026 | −$0.30 | −$0.34 | −13.4% | $7.4M | $2.3M | −69.5% | −0.9% |
| Apr 28, 2026 | −$0.34 | −$0.13 | +61.8% | $8.5M | $38.2M | +352.6% | +8.4% |
| Feb 26, 2026 | −$0.28 | −$0.30 | −7.1% | $16.1M | $17.2M | +7.4% | +5.6% |
| Nov 10, 2025 | −$0.30 | −$0.32 | −6.7% | $16.3M | $7.6M | −53.5% | −10.3% |
| Jul 30, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 4, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 6, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 3, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Jul 29, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 1, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 16, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Dec 17, 2015 | |||||||
| Jun 30, 2015 |